Post-Menopausal Women

 
In a study of more than 11,000 postmenopausal women in the United States, lower bone mineral density was associated with higher "social strain," a measure of negative social interactions and relationships. Weaker bones were associate with low levels of social activity.

While a direct causal link may not be documented, living an active life, having social support systems in place, thriving in relationships, and managing stress well, may be key components of both good health in general and bone health specifically. Contact the BioStrong team to learn more.

Medications know as “selective serotonin reuptake inhibitors” (SSRIs) were previously FDA approved to treat vasomotor symptoms associated with perimenopause such as; hot flashes, night sweats, sleep disturbance and some changes in mood. A study conducted by Sheu, Lanteigne, Sturmer, Pate, Azrael, & Miller (2015), entitled “SSRI Use and Risk of Fractures Among Perimenopausal Women without Mental Disorders”, and published in Injury Prevention, (Volume 21), showed increased fracture risk among middle-aged women prescribed SSRI’s for the treatment of perimenopausal vasomotor symptoms.

Decisions regarding medications, including; dose, cumulative dose, beginning a medication, stopping a medication and concerns regarding any potential side-effects should be thoroughly discussed with your primary care physician.